Search results for " stem cells patents"

showing 1 items of 1 documents

Recent patents and advances on isolation and cellular therapy applications of mesenchymal stem cells from human umbilical cord Wharton's jelly

2011

In recent years, important advances were made to clarify the biology and potential use of mesenchymal stem cells (MSC) in the therapy of a number of disorders. MSC are present in a number of tissues, ranging from adult bone marrow, to several adult organs, adipose tissue and, in the last years, the fetal-associated (also named as extraembryonic) tissues (e.g. placenta, amniotic membrane, umbilical cord). In particular, research on cells derived from mature umbilical cord, a tissue which is still discarded at birth, showed that mesenchymal stem cells can be successfully isolated from the Wharton’s jelly (WJ), the main constituent of this organ. This review will take in to account the patents…

Isolation (health care)business.industrySettore BIO/16 - Anatomia UmanaMesenchymal stem cellCell BiologyUmbilical cordCell biologyCell therapymedicine.anatomical_structureDevelopmental NeuroscienceWharton's jellyMedicinebusinessCellular therapy human umbilical cord hypoimmunogenicity immune regulation isolation and differentiation mesenchymal stem cells stem cells patents Wharton’s jellyDevelopmental Biology
researchProduct